Latest News


Research Excellence

Research shows your age and sex influence the impact of medications .

A new study by researchers at the Kolling Institute will directly guide the use of medications by older Australians after it identified the profound adverse effects of taking multiple medications. The study follows the latest figures which show around 50 per cent of Australians over 75 years take five or more medications every day to treat multiple chronic illnesses. The trend is leading.....
Read more

Category: Research Excellence

Exciting study to investigate new treatment for acute myeloid leukaemia.

The Cancer Council NSW today announced funding for a new stem cell team at the Kolling Institute to examine a revolutionary approach to treatment for those with acute myeloid leukaemia. This aggressive form of blood cancer has a tragically poor survival rate, and while we have seen tremendous progress for many other types of cancer in recent years, there have been very limited improvemen.....
Read more

Category: Funding support, Research Excellence

New cutting-edge technology coming to the Kolling.

The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leading technology, boosting our cancer and neuroscience research capabilities. The Digital Spatial Profiling System has been made possible following a $535,000 grant from the Australian Research Council LIEF scheme. The project is being co-funded by the University of Sydney with a $250,000 con.....
Read more

Category: Research Excellence, World-leading technology

Program supporting injured workers wins top award.

Kolling researchers have taken out a highly-competitive, national award for an innovative program helping people get back to work after injury. Professor Michael Nicholas and Dr Manasi Mittinty from the Pain Management Research Centre were part of a team which received a National Safety Award of Excellence for their initiative targeting injured workers. The program was trialled with staf.....
Read more

Category: Awards, Research Excellence

Researchers confirm extreme heat increases the risk of premature births.

Researchers have found that women are more likely to have a preterm birth when exposed to extreme heat and those with pre-existing conditions may have an even higher risk. Preterm or premature birth, when a baby is born before 37 weeks of pregnancy, is the leading cause of infant death worldwide and many children born early deal with ongoing health problems for the remainder of their liv.....
Read more

Category: Research Excellence

Study confirms deadly risk of COVID-19 for those with heart failure .

The largest study of its kind in Australia has found patients with a history of heart failure are three times more likely to die from COVID-19. Launched last year at the outset of the pandemic, the AUS-COVID trial is investigating those who are most at risk from COVID-19 in Australia. To date, it has assessed hundreds of patients in 21 hospitals across the country. The study confirmed ea.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Research identifies swallowing problems following whiplash.

Research conducted by a team from Kolling Institute has found that swallowing difficulties after a whiplash injury appear to be an under-recognised consequence of the injury. The study investigated a group of 60 patients with low-grade whiplash, finding 50 per cent of patients reported swallowing problems within 12 months of their whiplash injury. In 31 of these patients, there was a sta.....
Read more

Category: Musculoskeletal Research, Research Excellence

Researchers reject the use of plasma injections for knee joint osteoarthritis.

In what will be disappointing news for many, a large-scale clinical trial has found platelet-rich plasma injections for those with osteoarthritis knee pain are no better than a placebo. This type of injection has become an increasingly popular form of treatment for knee joint arthritis, despite its prohibitive cost at around $2,000 per injection. Plasma from a patient’s own blood is inje.....
Read more

Category: Research Excellence

Blueprint to strengthen research and improve the care we receive.

The Kolling’s new research plan has been confirmed marking an important milestone for the institute. The plan details the implementation of the institute’s five-year strategy, and will ensure the Kolling is in the best position to deliver game-changing research. Acting Executive Director Professor Jim Elliott has welcomed the development of the plan, saying a robust strategic framework w.....
Read more

Category: Research Excellence

High-profile appointment.

The Kolling Institute’s Executive Director Professor Carolyn Sue will join a dynamic group of Australian leaders on the new National Health and Medical Research Council. Professor Sue has been appointed to the high profile body for a three-year term until June 2024. A record number of women are represented on the new council, including chair and internationally-renowned researcher Profes.....
Read more

Category: Research Excellence